ChemFeeds Site Navigation:
Journal Selection:
Search:

99) NSCLC with Concomitant EGFR Mutations and ALK Rearrangements (Clinical Cancer Research) Monday March 3rd 2014


100) Vaccine and Glucan for Neuroblastoma (Clinical Cancer Research) Monday March 3rd 2014


101) Inflammation and Symptoms in Autologous Stem Cell Transplant (Clinical Cancer Research) Monday March 3rd 2014


102) Vaccine Responses after Adoptive T-Cell Transfers in Myeloma (Clinical Cancer Research) Monday March 3rd 2014


103) ARCON and Cancer-Related Anemia (Clinical Cancer Research) Monday March 3rd 2014


104) Phase I/II Trial of 17,20-Lyase Inhibitor Orteronel in mCRPC (Clinical Cancer Research) Monday March 3rd 2014


105) Molecular Classification of Mesothelioma (Clinical Cancer Research) Monday March 3rd 2014


106) CD276-Targeted Molecular Ultrasound in Ovarian Cancer (Clinical Cancer Research) Monday March 3rd 2014


107) Genetic Profile Correlated with Prostate Cancer Relapse (Clinical Cancer Research) Monday March 3rd 2014


108) PAM50 ROR Score and Late Distant Recurrence in Breast Cancer (Clinical Cancer Research) Monday March 3rd 2014


109) Ovarian Tumorgrafts as Patient Surrogates (Clinical Cancer Research) Monday March 3rd 2014


110) Synergistic Interaction between MPT0E028 and Sorafenib (Clinical Cancer Research) Monday March 3rd 2014


111) Nexrutine Inhibits Pancreatic Cancer via STAT3/NF-{kappa}B (Clinical Cancer Research) Monday March 3rd 2014


112) DAC Induces ROS Accumulation (Clinical Cancer Research) Monday March 3rd 2014


113) Inhibition of DNA Repair in Glioblastoma (Clinical Cancer Research) Monday March 3rd 2014


114) Combinatorial Immunotherapy of Poly-IC and Anti-PD-L1 mAb (Clinical Cancer Research) Monday March 3rd 2014


115) PI3K and RAS Inhibitor Treatments for Carcinoid Tumors (Clinical Cancer Research) Monday March 3rd 2014


116) Therapies for ALK-Positive Lung Cancer (Clinical Cancer Research) Monday March 3rd 2014


117) Trabectedin and SN38 Are Synergistic in Ewing Sarcoma Cells (Clinical Cancer Research) Monday March 3rd 2014


118) Let-7 miRNA and HMGA2 in Atypical Teratoid/Rhabdoid Tumor (Clinical Cancer Research) Monday March 3rd 2014


119) HRT, Body Weight, and Oophorectomy in Breast Cancer Risk (Clinical Cancer Research) Monday March 3rd 2014


120) MUTYH-Associated Polyposis in Patients with Serrated Polyps (Clinical Cancer Research) Monday March 3rd 2014


121) miR-202-3p Targets ARL5A in Colorectal Cancer (Clinical Cancer Research) Monday March 3rd 2014


122) Aberrant Splicing in AML Novel Markers and Potential Drug Targets (Clinical Cancer Research) Monday March 3rd 2014


123) Surveillance of the Ovarian Cancer Mutanome by T Cells (Clinical Cancer Research) Monday March 3rd 2014


124) LINE-1 Methylation and CDK6 in Esophageal Cancer (Clinical Cancer Research) Monday March 3rd 2014


125) COX-Independent Mechanisms of NSAID Chemoprevention (Clinical Cancer Research) Monday March 3rd 2014


126) NK Cells in DC Vaccination (Clinical Cancer Research) Monday March 3rd 2014


127) Aspirin and Colorectal Cancer (Clinical Cancer Research) Monday March 3rd 2014


128) Turning the Tide Against Cancer Through Sustained Medical Innovation (Clinical Cancer Research) Monday March 3rd 2014


129) Molecular Pathways: Targeting BRAFV600E Tumors (Clinical Cancer Research) Monday March 3rd 2014


130) Immunotherapy for Lung Cancer (Clinical Cancer Research) Monday March 3rd 2014


131) Molecular Precision Chemotherapy (Clinical Cancer Research) Monday March 3rd 2014


132) Genetic Work-up and Genotype-Phenotype Correlations in MAP (Clinical Cancer Research) Monday March 3rd 2014


133) Biomarkers and Response to Bevacizumab--Response (Clinical Cancer Research) Sunday February 16th 2014


134) Letter to the Editor (Clinical Cancer Research) Sunday February 16th 2014


135) GA201: A Novel Humanized and Glycoengineered Anti-EGFR Antibody--Response (Clinical Cancer Research) Sunday February 16th 2014


136) GA201: A Novel Humanized and Glycoengineered Anti-EGFR Antibody--Letter (Clinical Cancer Research) Sunday February 16th 2014


137) Bmal1 Increases Oxaliplatin Sensitivity in Colorectal Cancer (Clinical Cancer Research) Sunday February 16th 2014


138) Complement Activation and Rituximab Distribution in CNS NHL (Clinical Cancer Research) Sunday February 16th 2014


139) Mesothelin--A Marker of Tumor Aggressiveness in Lung Cancer (Clinical Cancer Research) Sunday February 16th 2014


140) Asymptomatic Monoclonal Cyclin D1-Positive B-cell Lymphocytosis (Clinical Cancer Research) Sunday February 16th 2014


141) Synergistic Antitumor Activity of Cetuximab and Namitecan (Clinical Cancer Research) Sunday February 16th 2014


142) Cellular Imatinib Transport Is Independent of OCT1 (Clinical Cancer Research) Sunday February 16th 2014


143) EGFRvIII mCARs for Malignant Glioma (Clinical Cancer Research) Sunday February 16th 2014


144) CSPG4-Specific CAR in Solid Tumors (Clinical Cancer Research) Sunday February 16th 2014


145) PKC and Twist1 in Androgen-Deprivation Therapy (Clinical Cancer Research) Sunday February 16th 2014


146) HGF/Met-Induced EMT in SCLC (Clinical Cancer Research) Sunday February 16th 2014


147) MCT1 Inhibition in Small Cell Lung Cancer (Clinical Cancer Research) Sunday February 16th 2014


148) BET Inhibition Medulloblastoma (Clinical Cancer Research) Sunday February 16th 2014


149) Telomere Content and Second Cancers in Pediatric Cancer Survivors (Clinical Cancer Research) Sunday February 16th 2014


150) RB1, TP53, and PTEN Loss in Prostatic Small Cell Carcinoma (Clinical Cancer Research) Sunday February 16th 2014


151) MicroRNA Network Predicts Gastric Cancer Survival (Clinical Cancer Research) Sunday February 16th 2014


152) Clusterin Is a microRNA-21 Target in Head and Neck Cancer (Clinical Cancer Research) Sunday February 16th 2014


153) Colonization of Human Gut by E. coli and Colorectal Cancer (Clinical Cancer Research) Sunday February 16th 2014


154) Endothelial HIF-1{alpha} and Relapsed/Refractory Multiple Myeloma (Clinical Cancer Research) Sunday February 16th 2014


155) Cancer Cell Chemoresistance and Yes/YAP Axis (Clinical Cancer Research) Sunday February 16th 2014


156) PID1 in Brain Tumors (Clinical Cancer Research) Sunday February 16th 2014


157) DNA Methyltransferase Inhibition Affecting NSCLC Methylome (Clinical Cancer Research) Sunday February 16th 2014


158) Biomarkers in Multiple Myeloma (Clinical Cancer Research) Sunday February 16th 2014


159) Metaboloepigenetic Effects of Butyrate in Colorectal Cancer Prevention (Clinical Cancer Research) Sunday February 16th 2014


160) Targeting the Androgen Receptor for Therapeutic Benefit (Clinical Cancer Research) Sunday February 16th 2014


161) Clinical Strategies for Triple-Negative Breast Cancer (Clinical Cancer Research) Sunday February 16th 2014


162) Telomere Length Determines Cancer Recurrence (Clinical Cancer Research) Sunday February 16th 2014


163) DNA Repair Mutations and Outcomes in Ovarian Cancer (Clinical Cancer Research) Monday February 3rd 2014


164) Busulfan Dose Prediction in Infants to Adults (Clinical Cancer Research) Monday February 3rd 2014


165) PIK3CA, BRAF, and PTEN in Advanced Colorectal Cancer Treated by Cetuximab or Best Supportive Care (Clinical Cancer Research) Monday February 3rd 2014


166) Low ER Expression as a Predictor of Response to Lapatinib (Clinical Cancer Research) Monday February 3rd 2014


167) Reduction of Tregs in AML via Epigenetic Therapies (Clinical Cancer Research) Monday February 3rd 2014


168) Collagen-Remodeling Gene Signature Predicts Poor Survival (Clinical Cancer Research) Monday February 3rd 2014


169) Complexity of Notch1 Mutations in Chinese OSCC (Clinical Cancer Research) Monday February 3rd 2014


170) MUC4 Regulates Lipocalin 2 through HER2/AKT/NF-{kappa}B Pathway (Clinical Cancer Research) Monday February 3rd 2014


171) Targeted Imaging of Ewing Sarcoma (Clinical Cancer Research) Monday February 3rd 2014


172) Chemoimmunotherapy for Canine DLBCL (Clinical Cancer Research) Monday February 3rd 2014


173) PDGFR{beta}-AKT Pathway Involved in CDDP Resistance in TGTs (Clinical Cancer Research) Monday February 3rd 2014


174) Cancer Radiotherapy Enhanced by Stromal Cell Destruction (Clinical Cancer Research) Monday February 3rd 2014


175) Targeting PI3K in SCLC (Clinical Cancer Research) Monday February 3rd 2014


176) Cabozantinib Inhibits Prostate Cancer Growth in Bone (Clinical Cancer Research) Monday February 3rd 2014


177) The Disparate Twins: CXCR4 and CXCR7 (Clinical Cancer Research) Monday February 3rd 2014


178) PI3K{beta} and PTEN Expression in NSCLC (Clinical Cancer Research) Monday February 3rd 2014


179) IL-30 and Prostate Cancer Progression (Clinical Cancer Research) Monday February 3rd 2014


180) SRD5A Polymorphisms and Androgens in Prostate Cancer (Clinical Cancer Research) Monday February 3rd 2014


181) Tumor Suppressive Effect of BRD7 in Ovarian Cancer (Clinical Cancer Research) Monday February 3rd 2014


182) Molecular Postulates for Peto's Paradox (Clinical Cancer Research) Monday February 3rd 2014


183) B-Cell Receptor Targeting in CLL (Clinical Cancer Research) Monday February 3rd 2014


184) PARP Inhibitor Resistance Mechanisms (Clinical Cancer Research) Monday February 3rd 2014


185) Adaptive Prediction in Molecular Signature-Based Studies (Clinical Cancer Research) Monday February 3rd 2014


186) Managing ER-Low/HER2-Negative Breast Cancer (Clinical Cancer Research) Monday February 3rd 2014


187) Cabozantinib and Prostate Cancer Metastasis (Clinical Cancer Research) Monday February 3rd 2014


188) PAM50 Subtype Predictor in HER2-Positive Breast Cancer (Clinical Cancer Research) Friday January 17th 2014


189) Neoadjuvant Imatinib in Dermatofibrosarcoma (Clinical Cancer Research) Friday January 17th 2014


190) Selumetinib in Acute Myelogenous Leukemia (Clinical Cancer Research) Friday January 17th 2014


191) Safety, Pharmacokinetics, and Antitumor Activity of Dalantercept (Clinical Cancer Research) Friday January 17th 2014


192) Novel Stem Cell Mobilizer (Clinical Cancer Research) Friday January 17th 2014


193) Enhanced Antitumor Activity with Trastuzumab Emtansine plus Pertuzumab (Clinical Cancer Research) Friday January 17th 2014


194) Phase I Study of BIIB021 (Clinical Cancer Research) Friday January 17th 2014


195) Prognostic Significance of CD103+ TILs in Ovarian Carcinoma (Clinical Cancer Research) Friday January 17th 2014


196) Prognostic Relevance of CTCs and DTCs in patients suffering from oral squamous cell carcinomas (Clinical Cancer Research) Friday January 17th 2014


View: prev | next

#RealTimeChem:

Announcements:


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()